101. | | Recruiting | Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer |
102. | | Recruiting | Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
103. | | Recruiting | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer Conditions: stage IIIA non-small cell lung cancer; squamous cell lung cancer; large cell lung cancer; adenocarcinoma of the lung; ... |
104. | | Recruiting | Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
105. | | Recruiting | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer |
106. | | Recruiting | Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer Conditions: stage III bladder cancer; recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ... |
107. | | Recruiting | Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium Conditions: anterior urethral cancer; localized transitional cell cancer of the renal pelvis and
ureter; posterior urethral cancer; stage II bladder cancer; ... |
108. | | Recruiting | Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Conditions: stage IV prostate cancer; recurrent prostate cancer |
109. | | Recruiting | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Conditions: stage IV squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the lip and oral cavity; ... |
110. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach Conditions: stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage I esophageal cancer; stage II esophageal cancer; ... |
111. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function Conditions: stage III bladder cancer; recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; recurrent urethral cancer; ... |
112. | | Recruiting | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer Conditions: stage IV colon cancer; stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IV gastric cancer; ... |
113. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
114. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
115. | | Recruiting | Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ... |
116. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Conditions: stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma |
117. | | Recruiting | Combination Chemotherapy Followed By Tipifarnib Plus Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
118. | | Recruiting | Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer |
119. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; squamous cell lung cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; ... |
120. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Conditions: stage III endometrial cancer; stage IV endometrial cancer; endometrial
adenocarcinoma; endometrial adenosquamous cell carcinoma; ... |
121. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer Conditions: stage 0 esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; ... |
122. | | Recruiting | Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
123. | | Recruiting | PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
124. | | Recruiting | Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer Conditions: squamous cell lung cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
125. | | Recruiting | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin Conditions: adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary |
126. | | Recruiting | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
127. | | Recruiting | Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
128. | | Recruiting | CT-2103 Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer |
129. | | Recruiting | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer |
130. | | Recruiting | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma Conditions: stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma; ... |
131. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
132. | | Recruiting | A Study Comparing Weekly Taxol and Carboplatin vs. Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer Condition: Carcinoma, Non-Small-Cell Lung |
133. | | Recruiting | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
134. | | Recruiting | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer |
135. | | Recruiting | Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer Conditions: stage II non-small cell lung cancer; squamous cell lung cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; ... |
136. | | Recruiting | CT-2103 Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
137. | | Recruiting | Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer Condition: stage I non-small cell lung cancer |
138. | | Completed | A Phase I Study of Infusional Paclitaxel with the P-Glycoprotein Antagonist PSC 833 Conditions: Breast Cancer; Cancer; Carcinoma, Renal Cell; Lymphoma; Ovarian Cancer |
139. | | Completed | A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy with G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stag... Conditions: Breast Cancer; Breast Neoplasms |
140. | | Completed | Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients with Stage III/IV and Relapsed NSCLC Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
141. | | Completed | Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients with Stage III Non-Small Cell Lung Cancer Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms |
142. | | No longer recruiting | A Pilot Study of Paclitaxel with Radiation Therapy for Locally Advanced Head and Neck Cancer Conditions: Head and Neck Neoplasm; Squamous Cell Carcinoma |
143. | | Recruiting | Safety and efficacy study of rhAngiostatin administered in combination with paclitaxel and carboplatin to patients with non-small-cell lung cancer Condition: Carcinoma, Non-Small-Cell Lung |
144. | | Completed | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis Conditions: Carcinoma; Peritoneal Neoplasm |
145. | | Recruiting | A Pilot Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide with Autologous Progenitor Cell Transplantation for the Treatment of Metastatic and High Risk Breast Cancer Conditions: Breast Neoplasm; Neoplasm Metastasis |
146. | | Completed | A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin with G-CSF Support in Patients with Advanced Ovarian Cancer Previously Treated with Paclitaxel and Cisplatin Condition: Ovarian Neoplasms |
147. | | Completed | A Pilot Trial of Sequential Chemotherapy with Antimetabolite Induction, High-Dose Alkylating Agent Consolidation with Peripheral Blood Progenitor Cell Support, and Intensification with Paclitaxel a... Conditions: Breast Cancer; Breast Neoplasms |
148. | | Recruiting | A Controlled, Randomized, Phase III, Multicenter, Open Label Study of ABI-007 and Taxol in Patients with Metastatic Breast Cancer Conditions: Breast
Neoplasms; Metastases, Neoplasm |
149. | | Recruiting | Treating Inoperable Lung Tumors With Heated Chemotherapy Medicine Delivered Solely to the Lung Conditions: Breast Cancer; Lung Cancer; Melanoma; Sarcoma; Pulmonary Metastases;
Taxol; Cytoprotection |
150. | | Recruiting | A Phase II Clinical Trial of ABI-007, Administered Weekly in Taxol Resistant Patients with Metastatic Breast Cancer Conditions: Breast
Neoplasms; Metastases, Neoplasm |